ABM
Happily Married In Music City, USA!
- Joined
- Sep 12, 2008
- Messages
- 31,865
- Likes
- 5,785
- Points
- 113
barfo's right...you are confused
Oleandrin has had no phase 1 or phase 2 trials. None
there have been scientific trials on cancer cells and the aids virus but there is no proven efficacy. No study of the drug has even been peer reviewed
Hard to say...
https://www.businesswire.com/news/h...-Study-Points-Potential-Oleandrin-Therapeutic
SAN ANTONIO--(BUSINESS WIRE)--A new research study recently published as an “In Press” article in the Journal of Antivirals & Antiretrovirals (www.longdom.org/antivirals-antiretrovirals.html) [Volume 11, Issue 3, 2019] concludes that “phytomedical compounds, such as the cardenolide oleandrin, may one day represent a cost-effective therapeutic strategy to help combat enveloped virus infections (such as HTLV-1) in developing countries with limited access to modern antivirals.”
“The Botanical Glycoside Oleandrin Inhibits Human T-cell Leukemia Virus Type-1 (HTLV-1) Infectivity and Env-Dependent Virological Synapse Formation.”
Tweet this
The study is the latest in a string of published research papers which speak to various potential uses of oleandrin, an extract from the common Nerium oleander plant, in disease treatments. Oleandrin is the key bioactive component of PBI-05204, a drug developed by Phoenix Biotechnology, Inc. (www.phoenixbiotechnology.com), of San Antonio, TX.
According to Robert A. Newman, PhD, President and Chief Science Officer of Phoenix Biotech, PBI-05204 is the only botanical drug that contains oleandrin which has gone through both Phase I and Phase II clinical trials and is currently under development.